GRI Bio Inc. (GRI) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for GRI Bio Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$1.62
+0.31% today
Market cap
$3M
Overall quality
—
Kronos AI 30-day
+3.7%
6 of 8 simulated paths end higher
GRI Bio Inc. (GRI) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $3M. It trades at $1.62, up 0.31% today. 1 analysts' average target of $27.00 implies +1566.7% from today's price. Kronos AI's 30-day forecast is +3.7% (6 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $27.00 |
| Low – high | $27.00 – $27.00 |
| Analysts | 1 |
| Upside to average | +1566.7% |
Kronos AI 30-day forecast
| Expected close | $1.64 (+3.7%) |
| Likely range | −2.6% … +7.2% |
| As of | 2026-10-27 |
6 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.